APPLICATION
ANDA077920
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MELOXICAMPrescription
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMPrescription
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 9 · standardAP
2023-12-28Labeling · Supplement 7 · standardAP
2018-06-22Manufacturing (CMC) · Supplement 4 · unknownAP
2016-12-06Manufacturing (CMC) · Supplement 3 · unknownAP
2007-10-25Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.